Status:
COMPLETED
Respiratory Outcome of Children From the FEPED Cohort
Lead Sponsor:
Assistance Publique - Hôpitaux de Paris
Conditions:
Asthma in Children
Eligibility:
All Genders
5-6 years
Brief Summary
Early lung function deficits represent a significant risk factor for the evolution toward chronic obstructive pulmonary disease later in life. Prematurity and in utero tobacco smoke exposure are alrea...
Detailed Description
Children aged 5 to 6 years old will be included from the FEPED cohort. The FEPED cohort is a cohort of French pregnant women designed to study the association between vitamin D status during pregnancy...
Eligibility Criteria
Inclusion
- term-born child (gestational age ≥ 37 weeks of post-menstrual age) whose mother was included in the FEPED cohort
- measure of vitamin D concentration available at the first and third trimester of pregnancy and in cord blood
- cord blood sample available for DNA extraction
- child's age between 5 and 6 years old at the time of participation
- written informed consent obtained from the legal guardian of the child
- health insurance
Exclusion
- parent's' refusal
- underlying disease that does not allow the performance of lung function tests
Key Trial Info
Start Date :
January 31 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 16 2020
Estimated Enrollment :
142 Patients enrolled
Trial Details
Trial ID
NCT03229317
Start Date
January 31 2018
End Date
December 16 2020
Last Update
May 3 2021
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Armand Trousseau Hospital
Paris, France, 75012
2
Necker Enfants-malades Hospital
Paris, France, 75015
3
Robert Debré Hospital
Paris, France, 75019